Search

Search results

Exercise Helps Improve Memory In People Over Age 50 - Study

... the progression of dementia which can eventually lead to Alzheimer's disease." During the trial, 170 volunteers aged 50 years and ... doesn't just have benefits for memory and preventing Alzheimer's disease, it highlights the importance of exercise to boost overall ...

Article - News Staff - Sep 2 2008 - 4:21pm - 0 attachments

ApoA-I Data Presented At European Society Of Cardiology Congress

... diseases such as acute coronary syndrome, diabetes, Alzheimer's disease and other vascular disorders. The Company's secondary focus ...

Article - Anna Ohlden - Sep 2 2008 - 12:33pm - 0 attachments

Phase 1b/2a Program Commences For RVX-208

... diseases such as acute coronary syndrome, diabetes, Alzheimer's disease and other vascular disorders. The Company's secondary focus ...

Article - Anna Ohlden - Aug 25 2008 - 9:31am - 0 attachments

Researchers Correct Age-Related Decline In Liver Function

... buildup of toxic material that is especially pronounced in Alzheimer's, Parkinson's disease, and other neurodegenerative disorders. ... age." Dr. Cuervo next plans to study animal models of Alzheimer's, Parkinson's and other neurodegenerative brain diseases to see ...

Article - News Staff - Aug 10 2008 - 12:41pm - 0 attachments

ProteoTech's Exebryl-1(R) Enters Human Clinical Trials For The Treatment Of Alzheimer's Disease

... beta-amyloid protein accumulation for the treatment of Alzheimer's disease. ProteoTech initiated its Phase 1 human trial on July 29, 2008. At the 2008 International Conference on Alzheimer's disease in Chicago last week, ProteoTech presented remarkable ...

Article - Anna Ohlden - Aug 7 2008 - 8:33am - 0 attachments

Shire Delivers Strong Quarter: Driven By $243m Of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.

... treatment of mild to moderately severe dementia of the Alzheimer's type, continue to grow. Litigation proceedings relating to 3TC, ...

Article - Anna Ohlden - Jul 31 2008 - 7:30am - 0 attachments

Intellect Neurosciences, Inc. Obtains Pivotal European Patent Related To Monoclonal Antibody Passive Immunization Treatment Of A

... monoclonal antibody platform for the treatment of Alzheimer's disease. The claims of the issued patent cover the ANTISENILIN(R) ... antibodies in preventing or inhibiting the progression of Alzheimer's disease. The technology is designed to promote the clearance of ...

Article - Anna Ohlden - Jul 31 2008 - 5:30am - 0 attachments

Resverlogix's Lead Drug Featured In Key Scientific Publication

... diseases such as acute coronary syndrome, diabetes, Alzheimer's disease and other vascular disorders. The Company's secondary focus ...

Article - Anna Ohlden - Jul 18 2008 - 8:32am - 0 attachments

Nicotine Has Some Neuroscience Benefits - Study

A team of London scientists have found clues for the potentially therapeutic benefits of nicotine on learning, memory and attention while minimising the risk of addiction. The research announced in Geneva today will assist the search for new drugs for d ...

Article - News Staff - Jul 14 2008 - 12:01am - 0 attachments

Proteins And The Chamber Of Doom

Indiana Jones isn't the only one who has great adventures, apparently proteins do also. Researchers have uncovered a a slippery tube that funnels proteins into a 'chamber of doom' where they are shredded and recycled into the building blocks of new pro ...

Article - News Staff - Jul 12 2008 - 11:36am - 0 attachments